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Background: The diagnostic value of C-reactive protein (CRP) level for pneumonia in children is
unknown. As a first step in the assessment of the value of CRP, a diagnostic study was per-
formed in children at an emergency department (ED).
Methods: In this cross-sectional study, data were retrospectively collected from children pre-
senting with suspected pneumonia at the ED of Antonius Hospital Nieuwegein in The
Netherlands between January 2007 and January 2012. Diagnostic outcome was pneumonia
yes/no according to independent radiologist. (Un)adjusted association between CRP level
and pneumonia and diagnostic value of CRP were calculated.
Results: Of 687 presenting children, 286 underwent both CRP measurement and chest radiog-
raphy. 148 had pneumonia (52%). The proportion of pneumonia increased with CRP level. Nega-
tive predictive values declined, but positive predictive values increased with higher CRP
thresholds. Univariable odds ratio for the association between CRP level and pneumonia was
1.2 (95% CI 1.11e1.21) per 10 mg/L increase. After adjustment for baseline characteristics
CRP level remained associated with pneumonia.
Conclusions: CRP level has independent diagnostic value for pneumonia in children presenting
at the ED with suspected pneumonia, but low levels do not exclude pneumonia in this setting.
These results prompt evaluation of CRP in primary care children with LRTI.
ª 2013 Elsevier Ltd. All rights reserved.ail.com (M.J. Koster).
3 Elsevier Ltd. All rights reserved.
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Lower respiratory tract infections (LRTIs) are common in
children and among the most frequent reasons for consul-
ting a general practitioner (GP).1 LRTIs comprise acute
bronchitis, bronchiolitis and pneumonia. While the latter
usually requires antibiotic treatment, the former two are
generally self-limiting and complications are rare when
antibiotics are withheld.2
Nonetheless, most children diagnosed with acute
bronchitis and bronchiolitis are prescribed antibiotics. A
large survey in Dutch general practice including over
75 000 children in 2001 showed that 83.5% of all children
presenting with acute bronchitis still received antibiotics,3
and recent studies confirmed these high prescription
numbers.4 Aside from the costs, the high prescription rates
are undesirable because of needless exposure of patients
to possible side effects,5 medicalisation of self-limiting
illness6 and increasing development of bacterial
resistance.7
An important reason for the high prescription rates could
be diagnostic uncertainty of the GP. It is difficult to
distinguish pneumonia from other LRTIs using history and
clinical examination only,8,9 and it is neither feasible nor
desirable to perform a chest radiograph in all children with
suspected LRTI.
C-reactive protein (CRP) measurement might be help-
ful in the diagnostic management of LRTI in children. CRP
is an acute phase protein synthesized by the liver in
response to IL-6. Plasma levels of CRP are generally very
low in healthy persons, but can rise rapidly in case of
acute inflammation.10,11 Studies have shown that CRP
could be helpful in the distinction of pneumonia from
other LRTIs in adults.12 However, these results cannot be
assumed to be completely applicable to children, due to
differences in immunity, causal agents, anatomy and
physiology.13
While there are some studies reporting on the ability of
CRP to discriminate between viral and bacterial infections
in children with pneumonia,14 hardly any data is available
on the diagnostic value of CRP to distinguish between
pneumonia and other LRTIs like acute bronchitis in chil-
dren. We are aware of only one previously published study
which investigated the ability of CRP to discriminate be-
tween presence or absence of pneumonia in children with
LRTI in secondary care. Babu et al.15 compared CRP levels
of 30 children with pneumonia to those of 30 children with
normal chest radiographs. The results showed 100% sensi-
tivity, specificity and predictive values when using a
threshold for CRP of 35 mg/L. However this study was very
small and its methodology had serious flaws.
Therefore, a logical first step in the assessment of the
diagnostic value of CRP in children to detect pneumonia,
seemed to be an observational study in secondary care,
because the prevalence of the target disorder, pneumonia,
is relatively high in this group and both CRP and chest ra-
diographs are part of the routine diagnostic work-up in this
setting.
The aim of this study was to determine the diagnostic
value of CRP in children visiting the emergency department
(ED), referred by their GP with suspected pneumonia.Methods
Design and study population
This was a diagnostic cross-sectional study with retrospec-
tive data collection. Eligible patients were children (aged
under 18), visiting the ED of the Antonius Hospital Nieu-
wegein in the Netherlands between January 2007 and
January 2012, suspected of pneumonia. Immunocompro-
mised children were excluded from analysis, as well as
children with chromosomal disorders (e.g. Down syn-
drome), developmental disorders, current malignancies
and children with chronic pulmonary disorders other than
asthma or recurrent viral wheezing.
Diagnostic outcome
The diagnostic outcome or reference test was pneumonia
presence or absence according to the chest radiograph. All
chest radiographs, taken during first presentation, were
reassessed in May 2012 by an independent chest radiologist
(PdJ) with 10 years experience in pediatric chest imaging.
This radiologist was blinded for earlier reports, as well as
for symptoms and signs of the presenting children. The
chest radiographs were classified as pneumonia, no pneu-
monia or inconclusive. For analysis, the latter two groups
were combined. A radiograph was said to show pneumonia
when it contained an opacity which was judged to be real
(no composition of vessels or bones) and acute (no residual
scars).16
The original radiology reports performed during the
actual presentation at the ED were used to calculate the
interobserver variability. The proportional agreement was
calculated as well as Cohen’s Kappa (k) to determine the
level of agreement. A k below 0.20 indicates poor agree-
ment, a k of 0.21e0.40 fair, a k of 0.41e0.60 moderate, a k
of 0.61e0.80 good and a k of 0.81e1.00 indicates very good
agreement between two observers.17
Analysis
The analyses were performed using SPSS 17.0. The main
analyses were done in the children of whom results of both
CRP level and a chest radiograph from the day of presen-
tation were available. Data were expressed as mean and
standard deviation (SD) for continuous variables and per-
centages and 95% confidence interval (CI) for categorical
variables.
Missing data were imputed for white blood cell count
(WBC), duration of fever and body temperature at first
presentation. Missing information regarding the use of an-
tibiotics or prednisone in the two weeks prior to presen-
tation and history of wheezing or asthma were not imputed
but assumed to be negative when missing, because lacking
information here was more likely to mean a negative result.
Patient characteristics including CRP level were
compared between the children with and without pneu-
monia, where children with inconclusive radiograph results
were included in the group without pneumonia, using
t-tests for continuous and chi square tests for categorical
Figure 1 Study patients.
Diagnostic properties of C-reactive protein 1089variables. The proportion of pneumonia was determined for
the following ranges of CRP level; below 20 mg/L,
20e50 mg/L, 50e100 mg/L, 100e200 mg/L and above
200 mg/L and univariable test characteristics (sensitivity,
specificity, predictive values and likelihood ratio’s) of CRP
level for pneumonia were calculated for the different
thresholds. The area under the receiver operating charac-
teristic (ROC) curve was calculated as a measure of
discrimination of CRP level.Table 1 Baseline characteristics of children presenting with LR
Included children:
radiograph perform
Study group M
Age, years 4.4 (4.3) 0
Male gender, N (%) 154 (54) 0
CRP, mg/L 89.3 (110.4) 0
WBC, 109/L 15.3 (8.3) 9
Duration of fever, days 4.3 (4.0) 3
Body temperature, C 38.7 (1.2) 8
Antibiotics given before first contact, N (%) 81 (28) 7
Prednisone given before first contact, N (%) 8 (3) 7
History of wheezing, N (%) 55 (19) 3
History of asthma, N (%) 24 (8) 3
Chest X-ray
Pneumonia, N (%) 148 (52) 0
No signs of pneumonia, N (%) 126 (44)
Inconclusive, N (%) 12 (4)
Presenting numbers are mean (SD), unless specified otherwise CRP, C
per Liter.After checking linearity of the association between
continuous variables (CRP, age, duration of symptoms),
logistic regression was used to calculate the univariate odds
ratio (OR) for the association between CRP level and other
patient characteristics and the diagnostic outcome
pneumonia.
Results
Fig. 1 shows the included and excluded children. Out of 687
children, 286 remained for analysis. 70 children were
excluded based on their health status, and another 331
because CRP and/or chest radiography results were not
available. The included children were slightly older and less
frequently had a history of wheezing compared to the 331
children with missing results (Table 1).
The mean age of the 286 included children was 4.4
years, 54% were male and their mean CRP level was 90 mg/
L. According to the chest radiographs 148 (52%) had pneu-
monia. The mean CRP level was higher in children with than
in those without pneumonia, respectively 141 mg/L and
34 mg/L. Mean WBC level was 18  109/L in children with
pneumonia and 13  109/L in children without pneumonia.
On average, the children in the pneumonia group were
older, had a longer period of (anamnestic) fever prior to
presentation and less often had a history of viral wheezing.
Other characteristics between the two groups did not differ
(Table 2).
The proportion of pneumonia increased with rising CRP
levels. In children with a CRP level below 20 mg/L, 28% had
pneumonia. For children with CRP levels of 20e50 mg/L,
50e100 mg/L, 100e200 mg/L and above 200 mg/L, the pro-
portion was 42%, 48%, 80% and 94% respectively (Table 3).
Sensitivity, specificity, predictive values and positive
and negative likelihood ratios for various thresholds are
shown in Table 4. Where negative predictive values (NPVs)TI: in- and excluded children.
CRP and chest
ed (N Z 286)
Excluded children: CRP test and/or chest
radiograph not performed (N Z 331)
issing, N (%) Study group Missing, N (%)
3.3 (3.3) 0
190 (57) 0
65.0 (78.5) 303 (92)
(3) 14.3 (8.4) 299 (90)
4 (12) 3.2 (3.4) 40 (12)
6 (30) 38.2 (2.9) 125 (38)
(2) 80 (24) 0
(2) 4 (1) 0
2 (11) 93 (28) 34 (10)
2 (11) 30 (9) 34 (10)
91 (28) 159 (48)
73 (22)
8 (2)
-reactive protein; WBC, white blood cell count; mg/L, milligrams
Table 2 Baseline characteristics of included children
(N Z 286).
Variable Pneumonia
(N Z 148)
No pneumonia
(N Z 138)
P value
Age, years 5.2 3.6 0.002
Male gender, % 55 52 0.585
CRP, mg/L 140.8 34.1 <0.001
WBC, 109/L 17.5 12.7 <0.001
Duration of fever, days 4.9 3.2 <0.001
Body temperature, C 38.8 38.6 0.076
Antibiotics given before
first contact, %
33 24 0.102
Prednisone given before
first contact, %
3 3 0.927
History of wheezing, % 16 27 0.036
History of asthma, % 8 11 0.462
Presenting numbers are mean, unless specified otherwise. CRP,
C-reactive protein; WBC, white blood cell count.
1090 M.J. Koster et al.declined, positive predictive values (PPVs) rose with
increasing thresholds for CRP level.
Univariately, CRP level, WBC level, age, duration of
fever prior to presentation and a history of wheezing were
associated with pneumonia (Table 5). OR for CRP per
10 mg/L elevation was 1.2 (95% CI 1.11e1.21). After
adjustment for other variables, the OR for CRP per 10 mg/L
remained 1.2 (95% CI 1.10e1.22).
The ROC for CRP for the detection of pneumonia is
shown in Fig. 2 and the accompanying ROC area was 0.79
(95%CI 0.73e0.84).
The proportions of agreement between the original
radiograph reports and the evaluation of the independent
radiologist were 82% for the non-pneumonia group and 78%
for the pneumonia group. Cohen’s kappa for reassessment
of the chest radiographs was 0.61 (95%CI 0.52e0.70).
Discussion
Main findings
In this study on the diagnostic value of CRP for pneumonia
in children visiting the ED with suspected LRTI, CRP level
was independently associated with pneumonia. High CRP
levels (>200 mg/L) had high PPVs, but low CRP levels didTable 3 Proportion of pneumonia by CRP level.
CRP category
(N of children)
Pneumonia N
(%)
No pneumonia N
(%)
<20 mg/L (101) 28 (28) 73 (72)
20e50 mg/L (59) 25 (42) 34 (58)
50e100 mg/L (40) 19 (48) 21 (52)
100e200 mg/L (35) 28 (80) 7 (20)
>200 mg/L (51) 48 (94) 3 (6)
Total (286) 148 (52) 138 (48)
CRP, C-reactive protein; mg/L, milligrams per liter.not result in high NPVs for pneumonia (maximum of 79%
with CRP threshold of 10 mg/L).
Strengths and limitations
This is the first study on diagnostic accuracy of CRP for
pneumonia in children in which a sufficiently large number
of pneumonia cases was included. The 148 children with
pneumonia according to their chest radiograph allowed for
a robust analysis of the associations between several CRP
levels and pneumonia presence or absence.
Nevertheless, our study has some limitations. Firstly,
this study was conducted with retrospective data collec-
tion. Because tests were not performed in all presenting
children, this could have led to a certain selection of chil-
dren. However, according to baseline characteristics, chil-
dren in whom both tests were performed did not seem to be
more ill than those with missing results on CRP measure-
ment and/or chest radiograph. The only difference was
that children in the latter group were younger (3.3 vs. 4.4
years, respectively) and more often had a history of
wheezing (28% vs. 19% respectively). Notably, the differ-
ences between the two groups are not likely to affect the
relationship between CRP and pneumonia, and therefore
we believe confounding caused by possible selection bias is
most likely to be very limited.
Another possible limitation is the use of chest radio-
graphs as a reference test for pneumonia. It is known that
chest radiographs are an imperfect gold standard for
pneumonia. Viral bronchiolitis, for example, can cause
signs on chest radiographs which can sometimes be iden-
tical to the signs of bacterial pneumonia. Furthermore, the
assessment of chest radiographs is susceptible to individual
interpretation.18 In order to use a uniform standard for all
children, all chest radiographs in this study were judged by
an independent, experienced radiologist.
In our analysis, the inconclusive chest radiographs were
classified as ‘no pneumonia’. For that reason, there may be
some misclassification, e.g. inconclusive chest radiographs
of children with pneumonia. If so, this could have influ-
enced the outcome. On the other hand, only a very small
number of cases was considered inconclusive (N Z 12).
Comparison with previous studies
As mentioned earlier, very little research has been done on
the diagnostic value of CRP for pneumonia in children. The
sole study investigating this issue in children with LRTI was
published by Babu et al.15 Their results included sensitivity,
specificity and predictive values of 100% using a CRP
threshold of 35 mg/L, which differ considerably from our
study results. An explanation might be the very small
number of children in Babu’s study. Moreover, in our study,
a more heterogeneous group of children with signs of LRTI
were studied, whereas in Babu’s report children with
bronchiolitis were excluded from analysis. Furthermore,
37% of the pneumonia cases in Babu’s study had signs of
substantial malnutrition, which may have affected the im-
mune status and, therefore, the outcome.
A recent study in children with fever, conducted by
Mintegi et al.,19 investigated the value of CRP in diagnosing
Table 4 Test characteristics of CRP level per threshold.
CRP threshold Sensitivity
(%)
Specificity
(%)
Negative predictive
value (%)
Positive predictive
value (%)
Positive likelihood
ratio
Negative likelihood
ratio
10 mg/L 90 40 79 62 1.50 0.25
20 mg/L 81 53 72 65 1.72 0.36
50 mg/L 64 78 67 75 2.91 0.46
75 mg/L 55 87 65 82 4.23 0.52
100 mg/L 51 93 64 88 7.29 0.53
200 mg/L 32 97 58 93 10.67 0.70
250 mg/L 23 99 56 97 23.00 0.78
CRP, C-reactive protein; mg/L, milligrams per liter.
Diagnostic properties of C-reactive protein 1091pneumonia in 188 children younger than 36 months pre-
senting in pediatric emergency departments. These chil-
dren had no symptoms of LRTI, but presented with high
fever without source. A threshold of 100 mg/L CRP level
was used to divide the children in two groups and the
proportion of pneumonia was determined in both groups.
When comparing the two groups, an OR of 3.42 was found.
Predictive values were not calculated in this study.
In contrast with the lack of studies in children, several
studies were performed in adults. Falk et al.12 conducted a
systematic review and compared results of eight studies.
Using a threshold of 20 mg/L resulted in pooled positive and
negative likelihood ratios of 2.10 and 0.33, respectively.
These resemble those found in our study: 1.72 and 0.36
respectively. Heterogeneous results were found in Falk’s
study when using higher thresholds. Using 100 mg/L as
threshold, positive and negative likelihood ratios varied
between 2.30 and 51.80 and between 0.35 and 0.92,
respectively. The wide range of these results makes it hard
to compare outcomes with the present results. In our study,
positive and negative likelihood ratios for a threshold of
100 mg/L were 7.29 and 0.73 respectively.
The interobserver variability was accompanied by a
kappa of 0.61 in our study which is slightly higher than re-
sults in earlier studies in adults.18,20 The fact that adults
have more abnormalities on their radiographs than chil-
dren, due to for example previous infections (scar tissue) or
pulmonary or cardiac disorders, may explain the differ-
ence. As in other studies, the proportional agreement inTable 5 Univariable and multivariable association of CRP with
Univariable
Or 95% CI
CRP per 10 mg/L 1.2 1.11e1.2
Age, years 1.1 1.03e1.1
Male gender 1.1 0.72e1.8
WBC, 109/L 1.1 1.05e1.1
Duration of fever, days 1.3 1.05e1.2
Body temperature, C 1.1 0.94e1.3
Antibiotics given before first contact 1.5 0.92e2.6
Prednisone given before first contact 0.9 0.23e3.8
History of wheezing 0.5 0.28e0.9
History of asthma 0.7 0.31e1.7
CRP, C-reactive protein; mg/L, milligrams per liter; WBC, white bloopositive cases was lower than those in negative cases. This
could mean that some children were wrongly considered
not to have pneumonia.Implications for practice/research
Even though the probability of pneumonia decreased with
lower CRP levels, pneumonia was present in 28% of children
with CRP levels below 20 mg/L. This is also reflected in the
relatively low negative predictive values; e.g. a threshold
of 10 mg/L for CRP resulted in an NPV of 79%. This means
that in this secondary care setting low values of CRP cannot
rule out pneumonia in children with suspected LRTI. High
values on the other hand, make the diagnosis pneumonia
more likely, reflected by high positive predictive values.
The children included in this study were all suspected of
having pneumonia. The pre-test probability was 52%.
Depending on the threshold used, measurement of CRP
could alter this to 62e97% given a high CRP level.
In general practice, pre-test probability of pneumonia is
probably much lower. Therefore, CRP measurement might
be even more beneficial in that setting. In case of LRTI, CRP
measurement is easier to obtain than chest radiographs and
is also less expensive. CRP testing, preferably with point of
care (POC) systems, might help to select children with a
serious infection and may help to reduce unnecessary use
of antibiotics. In a recent study in adults with LRTI, CRP
POC testing safely reduced the number of prescribedpneumonia.
Multivariable
P value Or 95% CI P value
1 <0.001 1.2 1.10e1.22 <0.001
6 0.003 1.1 0.99e1.15 0.094
1 0.584 1.0 0.53e1.86 0.988
2 <0.001 1.1 1.00e1.10 0.025
1 0.001 1.1 1.01e1.19 0.037
9 0.178 0.9 0.69e1.20 0.510
1 0.103 1.9 0.91e3.82 0.089
2 0.926 1.1 0.20e5.87 0.921
7 0.039 0.8 0.40e1.76 0.634
0 0.463 0.8 0.26e2.17 0.597
d cell count.
Figure 2 Reciever operating characteristic curve (ROC area)
of CRP for pneumonia.
1092 M.J. Koster et al.antibiotics.21 Our study results are encouraging to start a
prospective, multicenter study in general practice to gain
more insights in the discriminative value of CRP in children.
Conclusion
This diagnostic study in an Emergency Department setting
showed that CRP measurement could be of additional value
in differentiating pneumonia from other LRTIs. High values
of CRP show PPVs up to 97%. The high PPVs implicate that it
would be justifiable to start treatment for pneumonia in
children with high CRP levels, without awaiting the results
of chest radiographs.
For primary care, merits are expected to be larger,
because of less distinct clinical pictures, the impracticality
of making chest X-rays in all symptomatic children and
lower probability of pneumonia in this setting. A prospec-
tive study in general practice is therefore warranted.
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